Skip to main content
UNION KOREA PHARM CO.,Ltd logo

UNION KOREA PHARM CO.,Ltd — Investor Relations & Filings

Ticker · 080720 ISIN · KR7080720006 KO Manufacturing
Open in API
Filings indexed 431 across all filing types
Latest filing 2025-06-26 Major Shareholding Noti…
Country KR South Korea
Listing KO 080720

About UNION KOREA PHARM CO.,Ltd

https://ukp.co.kr/

UNION KOREA PHARM CO.,Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and distribution of prescription drugs. The company produces a range of specialty medicines in various formulations, including solid dosage forms, liquid injections, and powders. Its product portfolio addresses therapeutic areas such as neoplasms, immune system diseases, anti-inflammatory analgesics, antibiotics, and skeletal muscle relaxants. The company emphasizes strict quality control throughout the entire production cycle, from raw materials to shipping, to ensure its products meet Good Manufacturing Practice (GMP) standards. It operates in both domestic and international markets.

Recent filings

Filing Released Lang Actions
기타시장안내(최대주주의의무보유관련) (최대주주의 의무보유 이행 관련)
Major Shareholding Notification Classification · 100% confidence The document is a short announcement (426 characters) from the Korea Exchange regarding a company's compliance with mandatory share holding requirements for a major shareholder. It does not contain full financial statements or detailed legal proceedings, but rather serves as a regulatory notification regarding market rules and compliance. As it is a specific regulatory announcement that does not fit into categories like dividend notices or share buybacks, it falls under the general regulatory filing category.
2025-06-26 Korean
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from the Korean stock market (DART system) announcing a change in the company's largest shareholder (최대주주변경). It details the transfer of shares due to the execution of a pledge (질권 실행), identifies the new major shareholder (주식회사 멜빈에프앤비), and provides financial and background information on the new entity. Since this is a specific regulatory disclosure regarding corporate ownership structure and does not fit into categories like M&A or Director's Dealing, it is classified as a general Regulatory Filing (RNS).
2025-06-24 Korean
기타시장안내(최대주주의의무보유관련)
Major Shareholding Notification Classification · 100% confidence The document is a regulatory notice from the Korea Exchange regarding a specific company (Korea Union Pharm) concerning the mandatory holding period for shares held by a new major shareholder. It is a regulatory announcement regarding market compliance and listing rules, which does not fit into specific categories like earnings, dividends, or director dealings. Therefore, it falls under the general regulatory filing category.
2025-06-24 Korean
기타시장안내 (상장적격성 실질심사 사유추가 안내 )
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice from the KOSDAQ market regarding 'Korea Union Pharm' concerning an additional reason for a listing eligibility review due to a change in the largest shareholder. It is a regulatory announcement issued by the exchange, not a financial report or a specific corporate action like a dividend or director dealing. Since it is a regulatory notification regarding listing status, it falls under the RNS category.
2025-06-24 Korean
[기재정정]분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the first quarter of 2025 (제 41 기 1분기) for '한국유니온제약(주)'. It contains detailed financial information, management discussion, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). Although it mentions a correction (정정), the document itself is the full quarterly report filing. Q1 2025
2025-05-15 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the first quarter of 2025 (제 41 기 1분기), covering the period from January 1, 2025, to March 31, 2025. It contains detailed company information, business descriptions, capital structure, and governance details, which are characteristic of a formal interim financial report filed with the Financial Supervisory Service (금융위원회) and the Korea Exchange (한국거래소). It is not an announcement of a report, but the report itself. Q1 2025
2025-05-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.